Institutions flex muscles in Glaxo pay vote

By 2003-05-20T04:15:00

UK – Shareholders have voted to reject a controversial pay package of the chief executive of drugs company GlaxoSmithKline - the first time a UK blue-chip company has had its pay scheme rejected by shareholders.

You have now reached your article limit

Already a registered user or member? Sign in here

To continue reading, register free today for access

Register Now

Registration also includes access to

IPE Real Assets

Gated access promo

Five reasons to register today

  1. Access to IPE articles from our award-winning editorial team
  2. Unique IPE market data, rankings and tables
  3. In-depth interviews with pension fund leaders
  4. Extensive coverage of latest asset class trends
  5. Comprehensive archive of data, research and intelligence